Revance therapeutics, inc. securities fraud lawsuit pending

Washington, dc / access newswire / january 28, 2025 / cohen milstein alerts investors that a complaint was filed on january 3, 2025 in the u.s. district court for the middle district of tennessee against revance therapeutics, inc. ("revance" or the "company") (nasdaq:rvnc), a biotechnology company that develops and commercializes neuromodulators. the complaint alleges that revance, mark.
RVNC Ratings Summary
RVNC Quant Ranking